BrandBacked Body Bemoans British Columbias Biosimilars Boost
A body supported by biologic originators has attacked British Columbias move to switch Crohns and colitis patient to infliximab biosimilars...&160;&160;
View ArticleTiziana Life Sciences Plc TILS Financial and Strategic SWOT Analysis Review...
Tiziana Life Sciences Plc TILS Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by...
View ArticleStempeutics Eyes Global Markets For New Crohn&39;s Symptom Cell Therapy
Stempeutics explores stem cell therapy in India for Crohns diseaserelated perianal fistulae while considering entry into other Asian markets.&160;&160;&160;
View ArticleSwitching from originator infliximab to CTP13 realworld data with 24 months...
A prospective observational study with moderatetosevere Crohns disease CD and ulcerative colitis UC patients switched from infliximab to CTP13 treatment was carried out at Hospital Universitario Virgen...
View ArticleSoligenix Inc SNGX Financial and Strategic SWOT Analysis Review Published by...
Soligenix Inc SNGX Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData...
View ArticleGenentechs Tecentriq Atezolizumab Improves Overall Survival as a Firstline...
Phase III IMpower110 study showed Tecentriq monotherapy helped people with advanced nonsmall cell lung cancer NSCLC with high PDL1 expression live longer compared with chemotherapy alone Data will be...
View ArticleDDT COA 000034 Crohns Disease PatientReported Outcomes Signs and Symptoms...
Office of Drug Evaluation ODE IIIDivision of Gastroenterology and Inborn Error Products DGIEPDDT COA NumberDDT COA 000034
View ArticleAmgen KRAS Inhibitor Less Effective In Colorectal Cancer Than Lung
New data for AMG 510 at ESMO show the drug is more active in lung than colorectal cancer as was...&160;&160;&160;
View ArticleNew technique may help improve understanding treatment of Crohn's disease
Scientists have developed a computer method that may help improve understanding and treatment of Crohn's disease which causes inflammation of the digestive tract.
View ArticleNew AI method may boost Crohn's disease insight and improve treatment
Scientists have developed a computer method that may help improve understanding and treatment of Crohn's disease which causes inflammation of the digestive tract. The study used artificial intelligence...
View ArticleGenentech Presents Positive Phase III Results for Tecentriq Atezolizumab in...
IMvigor130 is the first positive Phase III study of a cancer immunotherapy combination in people with previously untreated advanced bladder cancer Tecentriq combination reduced the risk of disease...
View ArticleHuman medicines European public assessment report EPAR Inflectra infliximab...
Human medicines European public assessment report EPAR Inflectra infliximab Arthritis PsoriaticSpondylitis AnkylosingColitis UlcerativePsoriasisCrohn DiseaseArthritis Rheumatoid Date of authorisation...
View ArticleHuman medicines European public assessment report EPAR Stelara ustekinumab...
Human medicines European public assessment report EPAR Stelara ustekinumab PsoriasisArthritis PsoriaticCrohn Disease Date of authorisation 15012009 Revision 29 Status Authorised
View ArticleNew CEO At MorphoSys Seeking Partner For CART Killer Lymphoma Drug
Analysts tip Munichbased company for greatness but it will need a big pharma partner to take on Roche&39;s Polivy in...&160;&160;&160;
View ArticleHuman medicines European public assessment report EPAR Remsima infliximab...
Human medicines European public assessment report EPAR Remsima infliximab Arthritis PsoriaticSpondylitis AnkylosingColitis UlcerativePsoriasisCrohn DiseaseArthritis Rheumatoid Date of authorisation...
View ArticleDr Reddys De Vr&233; On Momentum In US Biosimilars Market Interchangeability
The global head of Dr Reddys biologics business unit Raymond De Vr&233; discusses in an interview with Scrip how things...&160;&160;&160;
View ArticleInnovate Biopharmaceuticals to Merge with RDD Pharma Creating New...
Deep ClinicalStage Pipeline Combined With WorldClass Leadership TeamOrbiMed Advisors LLC to Lead a Concurrent Capital Raise 9 Meters Biopharma Inc. Will Be the New Name of the Combined NASDAQListed...
View ArticleCommon genetic variant explains why immunotherapy often fails in Crohn's disease
The reason why a commonly used range of immunotherapy drugs is not effective in some patients with Crohns disease has so far not been identified until now.
View Article